Browse > Article
http://dx.doi.org/10.6115/khea.2012.50.4.103

The Impact of Direct-to-Consumer Advertising of Prescription Medications on Healthy Lifestyle  

Yang, Hae-Kyung (Department of Consumer Information Science, Konkuk University)
Publication Information
Journal of the Korean Home Economics Association / v.50, no.4, 2012 , pp. 103-113 More about this Journal
Abstract
In the U.S. where Direct-to-Consumer Advertising (DTCA) of prescription medications is permitted, spending on DTCA has been accelerating. As a result, it has been an issue of intense public policy attention regarding whether DTCA is beneficial to the public by promoting a healthy lifestyle. Most of the literature concerning DTCA focuses on its impact on demand and empirical evidence regarding its impact on health-related behavior is scant. This study uses a database of DTCAs for high blood cholesterol, hypertension, diabetes, and overweight treatment medications that have appeared in nationally circulated U.S. consumer magazines during 2000 to 2004 and the Simmons National Consumer Survey in order to compute the level of individual advertising exposure and examines whether those who are exposed to DTCA are more likely to engage in regular exercise and diet control. The study finds evidence that for those with chronic conditions, greater exposure to DTCA leads to less exercise but more diet control. By therapeutic class level, exposure to DTCA leads to less exercise for those with hypertension and who are overweight, whereas those with high blood cholesterol are more likely to engage in regular exercise. Looking into differential responses by socioeconomic status, those with less education are more likely to engage in exercise after being exposed to DTCA. The results imply that the effects of DTCA vary by therapeutic class. In order to enhance the benefits of DTCA, it is important to closely monitor the messages in DTCA and require it to include messages that promote lifestyle change should it be a part of the treatment.
Keywords
direct-to-consumer advertising; advertising exposure; health-related behavior;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wosinska, M. (2005). Direct-to-Consumer Advertising and Drug Therapy Compliance. Journal of Marketing Research, 42(3), 323-332.   DOI   ScienceOn
2 Yang, H. K. (2011a). The Impact of Direct-to-Consumer Advertising on Consumer Behavior. Journal of Consumer Studies, 22(3), 159-181.
3 Yang, H. K. (2011b). The Impact of Moving Pharmaceutical Products from Prescription Only to Over-the-Counter Status on Consumer Exposure to Advertising. International Journal of Human Ecology, 12(2), 1-12.   과학기술학회마을
4 Iizuka, T., & Jin, G. Z. (2007). Drug Advertising and Health Habit, mimeo.
5 Kaiser Family Foundation. (2001). Understanding the effects of direct-to-consumer prescription drug advertising. Menlo Park (CA): Henry J. Kaiser Family Foundation.
6 Meyerhoefer, C. D., & Zuvekas, S. H. (2008). The Shape of Demand: What Does It Tell Us About Direct-to-Consumer Marketing of Antidepressants?. B.E. Journal of Economic Analysis and Policy, 8(2), Article 4.
7 Murray, E., Lo, B., Pollack, L., Donelan, K., & Lee, K. (2004). Direct-to-Consumer Advertising: Public Perceptions of Its Effects on Health Behaviors, Health Care, and the Doctor-Patient Relationship. Journal of American Board of Family Practice, 17(1), 6-18.   DOI
8 National Institute of Health. (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication No. 98-4083. Washington, DC: National Institute of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
9 National Institute of Health. (2001). Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Third Report of the National Cholesterol Education Program Expert Panel. NIH Publication No. 01-3670. Washington, DC: National Institute of Health, National Heart, Lung, and Blood Institute.
10 National Institute of Health. (2004). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04-5230. Washington, DC: National Institute of Health, National Heart, Lung, and Blood Institute.
11 Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (1999). Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. Journal of Family Practice, 48, 446-452.
12 World Health Organization. (2008). 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Switzerland: WHO Document Production Services. Available at: http://whqlibdoc.who.int/publications/2009/9789241597418_eng.pdf.
13 Wooldridge, J. M. (2006). Introductory Econometrics (3rd ed.). Mason, Ohio: Thomson South-Western.
14 Avery R., Kenkel, D., Lillard, D., & Mathios, A. (2007). Private Profits and Public Health: Does Advertising of Smoking Cessation Products Encourage Smokers to Quit?. Journal of Political Economy, 115(3), 447-481.   DOI   ScienceOn
15 Chou, S-Y., Rashad, I., & Grossman, M. (2008). Fast-Food Restaurant Advertising on Television and Its Influence on Childhood Obesity. Journal of Law & Economics, 51(4), 599-618.   DOI   ScienceOn
16 Donohue, J. M., Berndt, E. R., Rosenthal, M., Epstein, A. M., & Frank, R. G. (2004). Effects of Pharmaceutical Promotion on Adherence to the Treatment Guidelines for Depression. Medical Care, 42(12), 1176-1185.   DOI   ScienceOn
17 Frosch, D. L., Suepattra, G. M., Tietbohl, C., & Pagan, J. A. (2011). Living in the "land of no"? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs. Social Science and Medicine, 73, 995-1002.   DOI   ScienceOn
18 Hornick, R. (2002). Public health communication: making sense of contradictory evidence. In R. C. Hornic (Ed.), Public health communication: Evidence for behavior change (pp. 1-19). Manwah, NJ: Lawrence Erlbaum Associated.
19 Iizuka, T., & Jin, G. Z. (2005). The Effect of Prescription Drug Advertising on Doctor Visits. Journal of Economics & Management Strategy, 14(3), 701-727.   DOI   ScienceOn
20 Iizuka, T. (2004). What Explains the Use of Direct-to-Consumer Advertising of Prescription Drugs?. Journal of Industrial Economics, 52(3), 349-379.   DOI   ScienceOn